Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (223)
Roivant Sciences Ltd. (ROIV)
Venker Eric — President & Immunovant CEO
Shares
200,000
Price
$30.27
Total Value
$6.05M
Shares Held After
1,613,063
% of Holdings
11.0%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
80
Price
$519.98
Total Value
$41.60K
Shares Held After
22,015
% of Holdings
0.4%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
782
Price
$518.76
Total Value
$405.67K
Shares Held After
22,095
% of Holdings
3.4%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
1,497
Price
$517.59
Total Value
$774.84K
Shares Held After
22,877
% of Holdings
6.1%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
723
Price
$516.87
Total Value
$373.69K
Shares Held After
24,374
% of Holdings
2.9%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
657
Price
$515.92
Total Value
$338.96K
Shares Held After
25,097
% of Holdings
2.6%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
343
Price
$514.67
Total Value
$176.53K
Shares Held After
25,754
% of Holdings
1.3%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
40
Price
$512.97
Total Value
$20.52K
Shares Held After
26,097
% of Holdings
0.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
439
Price
$512.50
Total Value
$224.99K
Shares Held After
26,137
% of Holdings
1.7%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
610
Price
$511.40
Total Value
$311.95K
Shares Held After
26,576
% of Holdings
2.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
151
Price
$510.36
Total Value
$77.06K
Shares Held After
27,186
% of Holdings
0.6%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
320
Price
$508.24
Total Value
$162.64K
Shares Held After
27,337
% of Holdings
1.2%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Levy Richard S — Director
Shares
40
Price
$506.68
Total Value
$20.27K
Shares Held After
27,657
% of Holdings
0.1%
ABEONA THERAPEUTICS INC. (ABEO)
Alvino Mark — Director
Shares
6,500
Price
$5.46
Total Value
$35.46K
Shares Held After
77,565
% of Holdings
7.7%
INSMED Inc (INSM)
Smith Michael Alexander — Chief Legal Officer
Shares
6,149
Price
$108.47
Total Value
$666.98K
Shares Held After
41,613
% of Holdings
12.9%
Moderna, Inc. (MRNA)
AFEYAN NOUBAR — Director
Shares
9,263
Price
$46.84
Total Value
$433.88K
Shares Held After
3,924
% of Holdings
70.2%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
12,820
Price
$6.15
Total Value
$78.84K
Shares Held After
700,000
% of Holdings
1.8%
ARDELYX, INC. (ARDX)
Kelliher Mike — Chief Business Officer
Shares
2,478
Price
$6.27
Total Value
$15.53K
Shares Held After
357,418
% of Holdings
0.7%
ARDELYX, INC. (ARDX)
Kelliher Mike — Chief Business Officer
Shares
1,870
Price
$6.27
Total Value
$11.72K
Shares Held After
359,896
% of Holdings
0.5%
ARDELYX, INC. (ARDX)
Kelliher Mike — Chief Business Officer
Shares
2,900
Price
$6.27
Total Value
$18.18K
Shares Held After
361,766
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
2,405
Price
$6.27
Total Value
$15.07K
Shares Held After
417,972
% of Holdings
0.6%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
2,427
Price
$6.27
Total Value
$15.21K
Shares Held After
420,377
% of Holdings
0.6%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
3,166
Price
$6.27
Total Value
$19.84K
Shares Held After
422,804
% of Holdings
0.7%
ARDELYX, INC. (ARDX)
Brady James Parker — Chief Human Resources Officer
Shares
1,846
Price
$6.27
Total Value
$11.57K
Shares Held After
261,066
% of Holdings
0.7%
ARVINAS, INC. (ARVN)
Teel Randy — Director
Shares
2,209
Price
$9.04
Total Value
$19.96K
Shares Held After
285,009
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Bishop John E — Chief Technical and Quality Officer
Shares
2,306
Price
$6.27
Total Value
$14.45K
Shares Held After
336,845
% of Holdings
0.7%
ARDELYX, INC. (ARDX)
Hohenleitner Susan — Chief Financial Officer
Shares
1,455
Price
$6.27
Total Value
$9.12K
Shares Held After
229,078
% of Holdings
0.6%
ARDELYX, INC. (ARDX)
Reilly Joseph James — Senior Vice President and Chief Accounting Officer
Shares
1,036
Price
$6.27
Total Value
$6.49K
Shares Held After
149,836
% of Holdings
0.7%
ARDELYX, INC. (ARDX)
Reilly Joseph James — Senior Vice President and Chief Accounting Officer
Shares
2,683
Price
$6.27
Total Value
$16.82K
Shares Held After
149,107
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,197
Price
$566.12
Total Value
$1.24M
Shares Held After
18,876
% of Holdings
10.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,765
Price
$565.10
Total Value
$997.41K
Shares Held After
21,073
% of Holdings
7.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,081
Price
$564.10
Total Value
$1.17M
Shares Held After
22,838
% of Holdings
8.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,677
Price
$563.12
Total Value
$1.51M
Shares Held After
24,919
% of Holdings
9.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
920
Price
$562.01
Total Value
$517.05K
Shares Held After
27,596
% of Holdings
3.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
320
Price
$560.03
Total Value
$179.21K
Shares Held After
28,516
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$557.85
Total Value
$22.31K
Shares Held After
28,836
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$566.42
Total Value
$90.63K
Shares Held After
40,513
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,259
Price
$566.02
Total Value
$1.28M
Shares Held After
40,673
% of Holdings
5.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,840
Price
$564.87
Total Value
$1.04M
Shares Held After
42,932
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,242
Price
$563.77
Total Value
$1.26M
Shares Held After
44,772
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,760
Price
$562.98
Total Value
$990.84K
Shares Held After
47,014
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
919
Price
$561.97
Total Value
$516.45K
Shares Held After
48,774
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$560.03
Total Value
$156.81K
Shares Held After
49,693
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$557.85
Total Value
$22.31K
Shares Held After
49,973
% of Holdings
0.1%
Oruka Therapeutics, Inc. (ORKA)
Dambkowski Carl — Director
Shares
13,235
Price
$59.97
Total Value
$793.66K
Shares Held After
73,743
% of Holdings
15.2%
Oruka Therapeutics, Inc. (ORKA)
Dambkowski Carl — Director
Shares
53,447
Price
$59.10
Total Value
$3.16M
Shares Held After
86,978
% of Holdings
38.1%
Oruka Therapeutics, Inc. (ORKA)
Dambkowski Carl — Director
Shares
38,318
Price
$58.43
Total Value
$2.24M
Shares Held After
140,425
% of Holdings
21.4%
Monte Rosa Therapeutics, Inc. (GLUE)
Manning Anthony M. — Director
Shares
10,000
Price
$18.01
Total Value
$180.10K
Shares Held After
0
% of Holdings
100.0%
Kura Oncology, Inc. (KURA)
Powl Brian T. — Chief Commercial Officer
Shares
10,000
Price
$11.00
Total Value
$110.00K
Shares Held After
173,614
% of Holdings
5.4%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
14,028
Price
$6.27
Total Value
$87.92K
Shares Held After
1,720,033
% of Holdings
0.8%
Showing 1–50 of 223 transactions (page 1 of 5)